GRI Bio, Inc.
GRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001824293
No open-market purchases or sales by GRI Bio, Inc. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $164.7K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in GRI Bio, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −4 vs. Q4 2022
- Shares held
- 104.4K
- −206.5K (−66.4%) vs. Q4 2022
- Total value
- $37.4K
- −$51.1K (−57.7%) vs. Q4 2022
- New holders
- 2
- 1 more added
- Sold out
- 6
- 2 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GRI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 11 | $164.7K |
| Q1 2026 | 6 | $64.7K |
| Q4 2025 | 7 | $14.7K |
| Q3 2025 | 8 | $276.8K |
| Q2 2025 | 5 | $25.3K |
| Q1 2025 | 5 | $15.5K |
| Q4 2024 | 8 | $185.2K |
| Q3 2024 | 7 | $49.7K |
| Q2 2024 | 5 | $139.7K |
| Q1 2024 | 6 | $177.2K |
| Q4 2023 | 9 | $82.8K |
| Q3 2023 | 6 | $887.2K |
| Q2 2023 | 5 | $5.09M |
| Q1 2023 | 9 | $37.4K |
| Q4 2022 | 13 | $88.5K |
| Q3 2022 | 8 | $74.0K |
| Q2 2022 | 10 | $141.0K |
| Q1 2022 | 13 | $765.0K |
| Q4 2021 | 13 | $2.86M |
| Q3 2021 | 12 | $2.75M |
| Q2 2021 | 11 | $3.15M |
| Q1 2021 | 10 | $2.44M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding GRI Bio, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Securities, LLC | 22,708 | $8.21K | 0.00% | −13,896−38.0% | Reduced |
| Geode Capital Management, LLC | 21,569 | $7.80K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 18,921 | $6.84K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 15,109 | $5.46K | 0.00% | +15,109 | New |
| Citadel Advisors LLC | 11,095 | $4.01K | 0.00% | +11,095 | New |
| Tower Research Capital LLC (TRC) | 11,907 | $4.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,919 | $1.06K | 0.00% | −17,428−85.7% | Reduced |
| Archer Investment Corp | 100 | $36 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 58 | $21 | 0.00% | +1+1.8% | Added |
| Virtu Financial LLC | 0 | $0 | 0.00% | −106,120−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −62,836−100.0% | Sold out |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −11,711−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −10,350−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,274−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −90−100.0% | Sold out |